SCHEMBL730025

SCHEMBL730025

c1ccc2c(c1)COO2

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6093132 1.00
SCHEMBL29386319 1.00
SCHEMBL8710 1.00
Hydrochloric Acid SCHEMBL6762162 0.97 MAOA (0.42)
Ammonia Solution, Strong SCHEMBL3205764 0.97 MAOA (0.42)
SCHEMBL3682309 0.97 MAOA (0.42)
Methane SCHEMBL10528050 0.97 MAOA (0.42)
SCHEMBL181520 0.91 MAOA (0.38)
SCHEMBL7234494 0.89 ABCG2 (0.58)
Piperazine SCHEMBL5564115 0.89 HTR2C (0.43)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023107623-A2 BICYCLIC HETEROARENES AND METHODS OF THEIR USE Kineta, Inc. (US) 2023-06-15 WO claimed
US-7601712-B2 Such as (1)-2-(4-chloro-3-((2-chloro-4-(((2S)-4-methyl-3,4-dihydro-2H-1,4-benzoxazin-2-ly)methoxy)benzoyl)amino)phenyl)-2-methylpropanoic acid; prostaglandin receptor agonists ONO PHARMACEUTICAL CO., LTD. (JP) 2009-10-13 US claimed
US-20070004716-A1 Carboxylic acid compounds and medicinal compositions containing the same as the active ingredient ONO PHARMACEUTICAL CO., LTD. (JP) 2007-01-04 US claimed
EP-1666473-A1 CARBOXYLIC ACID COMPOUNDS AND MEDICINAL COMPOSITIONS CONTAINING THE SAME AS THE ACTIVE INGREDIENT ONO PHARMACEUTICAL CO., LTD. (JP) 2006-06-07 EP claimed
US-4346228-A Novel 11-oxoprostaglandin derivatives SCHERING AKTIENGESELLSCHAFT (DE) 1982-08-24 US claimed
US-4088775-A PROSTAGLANDINS WITH LONG LASTING ACTIVITY SCHERING AKTIENGESELLSCHAFT (DT) 1978-05-09 US claimed
WO-2023107623-A2 BICYCLIC HETEROARENES AND METHODS OF THEIR USE Kineta, Inc. (US) 2023-06-15 WO disclosed
US-8557860-B2 Cyclopentane heptan(ENE)OIC acid, 2-heteroarylalkenyl derivatives as therapeutic agents ALLERGAN, INC. (US) 2013-10-15 US disclosed
EP-1666473-B1 CARBOXYLIC ACID COMPOUNDS AND MEDICINAL COMPOSITIONS CONTAINING THE SAME AS THE ACTIVE INGREDIENT ONO PHARMACEUTICAL CO (JP) 2013-01-02 EP disclosed
US-8168680-B2 Cyclopentane heptan(ENE)OIC acid, 2-heteroarylalkenyl derivatives as therapeutic agents ALLERGAN, INC. (US) 2012-05-01 US disclosed
US-8138335-B2 Carboxylic acid compounds and medicinal compositions containing the same as the active ingredient ONO PHARMACEUTICAL CO., LTD (JP) 2012-03-20 US disclosed
EP-2331533-A1 HETEROCYCLICALLY SUBSTITUTED ANILINOPYRIMIDINES AS FUNGICIDES Bayer CropScience AG (DE) 2011-06-15 EP disclosed
US-20110130439-A1 CYCLOPENTANE HEPTAN(ENE)OIC ACID, 2-HETEROARYLALKENYL DERIVATIVES AS THERAPEUTIC AGENTS ALLERGAN, INC. (US) 2011-06-02 US disclosed
EP-1666473-A1 CARBOXYLIC ACID COMPOUNDS AND MEDICINAL COMPOSITIONS CONTAINING THE SAME AS THE ACTIVE INGREDIENT ONO PHARMACEUTICAL CO., LTD. (JP) 2006-06-07 EP disclosed
WO-2006022974-A1 2-HETEROARYLALKENYLCYCLOPENTANE HEPTAN - (ENE) - OIC ACID DERIVATIVES AS THERAPEUTC AGENTS ALLERGAN, INC. (US) 2006-03-02 WO disclosed
WO-2006020510-A1 CYCLOPENTANE HEPTAN(ENE)OIC ACID, 2-HETEROARYLALKENYL DERIVATIVES AND THEIR USE AS PROSTAGLANDIN RECEPTOR MODULATORS ALLERGAN INC. (US) 2006-02-23 WO disclosed
US-20060035960-A1 Cyclopentane heptan(ene)oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents ALLERGAN, INC. (US) 2006-02-16 US disclosed
US-20060035949-A1 Cyclopentane heptan(ENE)OIC acid, 2-heteroarylalkenyl derivatives as therapeutic agents ALLERGAN, INC. (US) 2006-02-16 US disclosed
US-4346228-A Novel 11-oxoprostaglandin derivatives SCHERING AKTIENGESELLSCHAFT (DE) 1982-08-24 US disclosed
US-4346228-A Novel 11-oxoprostaglandin derivatives SCHERING AKTIENGESELLSCHAFT (DE) 1982-08-24 US disclosed